eF-site ID 2vth-A
PDB Code 2vth
Chain A

click to enlarge
Title Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H-pyrazole-3-carboxamide (AT7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment-Based X-Ray Crystallography and Structure Based Drug Design
Classification TRANSFERASE
Compound CELL DIVISION PROTEIN KINASE 2
Source Homo sapiens (Human) (CDK2_HUMAN)
Sequence A:  MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRSTAI
REISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKK
FMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLK
PQNLLINTEGAIKLADFGLARAFVTLWYRAPEILLGCKYY
STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG
TPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGR
SLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
Description (1)  CELL DIVISION PROTEIN KINASE 2 (E.C.2.7.11.1, 2.7.11.22)


Functional site

1) chain A
residue 137
type
sequence T
description BINDING SITE FOR RESIDUE GOL A 1299
source : AC1

2) chain A
residue 138
type
sequence E
description BINDING SITE FOR RESIDUE GOL A 1299
source : AC1

3) chain A
residue 257
type
sequence E
description BINDING SITE FOR RESIDUE GOL A 1299
source : AC1

4) chain A
residue 260
type
sequence R
description BINDING SITE FOR RESIDUE GOL A 1299
source : AC1

5) chain A
residue 261
type
sequence S
description BINDING SITE FOR RESIDUE GOL A 1299
source : AC1

6) chain A
residue 18
type
sequence V
description BINDING SITE FOR RESIDUE LZ2 A 1300
source : AC2

7) chain A
residue 31
type
sequence A
description BINDING SITE FOR RESIDUE LZ2 A 1300
source : AC2

8) chain A
residue 80
type
sequence F
description BINDING SITE FOR RESIDUE LZ2 A 1300
source : AC2

9) chain A
residue 81
type
sequence E
description BINDING SITE FOR RESIDUE LZ2 A 1300
source : AC2

10) chain A
residue 82
type
sequence F
description BINDING SITE FOR RESIDUE LZ2 A 1300
source : AC2

11) chain A
residue 83
type
sequence L
description BINDING SITE FOR RESIDUE LZ2 A 1300
source : AC2

12) chain A
residue 131
type
sequence Q
description BINDING SITE FOR RESIDUE LZ2 A 1300
source : AC2

13) chain A
residue 134
type
sequence L
description BINDING SITE FOR RESIDUE LZ2 A 1300
source : AC2

14) chain A
residue 127
type ACT_SITE
sequence D
description Proton acceptor
source Swiss-Prot : SWS_FT_FI1

15) chain A
residue 132
type BINDING
sequence N
description BINDING => ECO:0000269|PubMed:21565702
source Swiss-Prot : SWS_FT_FI3

16) chain A
residue 145
type BINDING
sequence D
description BINDING => ECO:0000269|PubMed:21565702
source Swiss-Prot : SWS_FT_FI3

17) chain A
residue 9
type SITE
sequence K
description CDK7 binding
source Swiss-Prot : SWS_FT_FI4

18) chain A
residue 88
type SITE
sequence K
description CDK7 binding
source Swiss-Prot : SWS_FT_FI4

19) chain A
residue 166
type SITE
sequence L
description CDK7 binding
source Swiss-Prot : SWS_FT_FI4

20) chain A
residue 6
type MOD_RES
sequence K
description N6-acetyllysine => ECO:0007744|PubMed:19608861
source Swiss-Prot : SWS_FT_FI6

21) chain A
residue 14
type MOD_RES
sequence T
description Phosphothreonine => ECO:0000269|PubMed:1396589, ECO:0000269|PubMed:17095507
source Swiss-Prot : SWS_FT_FI7

22) chain A
residue 10-33
type prosite
sequence IGEGTYGVVYKARNKLTGEVVALK
description PROTEIN_KINASE_ATP Protein kinases ATP-binding region signature. IGEGTYGVVYkArnkltgev..........VALK
source prosite : PS00107

23) chain A
residue 123-135
type prosite
sequence VLHRDLKPQNLLI
description PROTEIN_KINASE_ST Serine/Threonine protein kinases active-site signature. VlHrDLKpqNLLI
source prosite : PS00108

24) chain A
residue 1
type MOD_RES
sequence M
description N-acetylmethionine => ECO:0007744|PubMed:22814378
source Swiss-Prot : SWS_FT_FI5

25) chain A
residue 15
type MOD_RES
sequence Y
description Phosphotyrosine; by WEE1 => ECO:0000269|PubMed:1396589, ECO:0000269|PubMed:17095507, ECO:0007744|PubMed:19690332
source Swiss-Prot : SWS_FT_FI8

26) chain A
residue 19
type MOD_RES
sequence Y
description Phosphotyrosine => ECO:0007744|PubMed:19369195
source Swiss-Prot : SWS_FT_FI9

27) chain A
residue 33
type BINDING
sequence K
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000269|PubMed:17095507, ECO:0000269|PubMed:21565702
source Swiss-Prot : SWS_FT_FI2

28) chain A
residue 81
type BINDING
sequence E
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000269|PubMed:17095507, ECO:0000269|PubMed:21565702
source Swiss-Prot : SWS_FT_FI2

29) chain A
residue 86
type BINDING
sequence D
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000269|PubMed:17095507, ECO:0000269|PubMed:21565702
source Swiss-Prot : SWS_FT_FI2

30) chain A
residue 129
type BINDING
sequence K
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000269|PubMed:17095507, ECO:0000269|PubMed:21565702
source Swiss-Prot : SWS_FT_FI2

31) chain A
residue 10
type BINDING
sequence I
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000269|PubMed:17095507, ECO:0000269|PubMed:21565702
source Swiss-Prot : SWS_FT_FI2


Display surface

Download
Links